There is a mountain of drugs waiting to hit the market, and keeping up with their approval status is almost unviable. But the Prescribe Right Pharmaceutical Pipeline Tracker provides a cost effective way to monitor drugs in development.  Our database is continuously updated to provide the most current information.  We keep you up-to-date on late phase drug development, and when a new drug has the best chance for approval.  Information is implemented from the best available sources, beginning with published clinical studies.  Meeting presentations and announcements are also used in order to provide the most current information, while considering the information has not gone through a peer review process.
   
The Pharmaceutical Pipeline Tracker allows you to review drugs in development:
       
By searching for a single drug you can review (single drug sample report):
  • classification information
  • the mechanism of action
  • a summary of efficacy
  • safety information
  • news or analysis for the drug (e.g. FDA actions, analyst’s forecasts)
  • citations and conclusions from published studies.
  
Searches for groups of drugs allow you to review a table for products being developed for the same indication, drug class, therapeutic area or company research pipeline. 
   
We provide the information you need to track the pharmaceutical pipeline in a budget friendly manner. Other database services  cost ten times more than the Prescribe Right Pharmaceutical Pipeline Tracker and are not designed for formulary committees. Our annual subscription is $995, which is a 28% discount on the $115 monthly charge and includes updates, enhancements and access to our database of 1,148 drugs in development and 3,128 citations.  Don’t delay, start your subscription today and access the information you need to stay current within the drug development pipeline with the Prescribe Right Pharmaceutical Pipeline Tracker.